PFE Pfizer
$26.76 +2.14%
US Stock · Healthcare
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+2.14%
YTD
+8.90%
P/E
34.82
P/B
1.64
ROE
4.9%
Div yield
6.6%
Beta
0.3
Market cap
$150.9B
RSI (14)
76
Next earnings
Nov 2, 2026
Previous session
close of Aug 7, 2026 · EOD, no live order bookOpen
$26.22
Close
$26.76
VWAP (n/a)
—
Day high
$26.76
Day low
$26.05
Volume
36.1M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Yahoo Finance · Aug 7
The Two Divergent Paths Priced Into Eli Lilly Stock
Yahoo Finance · Aug 7
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised
Yahoo Finance · Aug 7
Stock Market Pro Chooses The Best ETFs To Own
Yahoo Finance · Aug 7
Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other Players
Yahoo Finance · Aug 7
Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...
Yahoo Finance · Aug 7
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View → 8-K Jun 18, 2026 View → 8-K Jun 18, 2026 View → 10-Q May 5, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell PFE. Try it in the Lab to size a position and see the risk.